Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise impact on blood glucose with detemir, glargine, and NPH in type 1 diabetes
2005-003980-21Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir, insulin glargine, human insulin and insulin aspart in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Novo Nordisk. Started Dec 2005; status: completed.
02
Drugs
insulin detemirinsulin glarginehuman insulininsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2005-003980-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003980-21.